Currently out of the existing stock ratings of Reni Benjamin, 218 are a BUY (86.17%), 35 are a HOLD (13.83%).

Reni Benjamin

Work Performance Price Targets & Ratings Chart

Analyst Reni Benjamin, currently employed at JMP, carries an average stock price target met ratio of 54.51% that have a potential upside of 56.63% achieved within 339 days. Previously, Reni Benjamin worked at RAYMOND JAMES, HC WAINWRIGHT.

Reni Benjamin’s has documented 454 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PRLD, Prelude Therapeutics at 11-Mar-2026.

Wall Street Analyst Reni Benjamin

Analyst best performing recommendations are on SANA (SANA BIOTECHNOLOGY).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 3/3/2026. The price target of $5 was fulfilled within 3 days with a profit of $1.25 (33.33%) receiving and performance score of 111.11.

Average potential price target upside

of $130.38 (84.01%) on ACET (ADICET BIO).
of $44.02 (65.12%) on STRO (SUTRO BIOPHARMA).
of $41.17 on INBX (INHIBRX ).

BCYC Bicycle Therapeutics Ltd BPMC Blueprint Medicines Corp DCPH Deciphera Pharmaceuticals LLC EFTR Effector Therapeutics INBX Inhibrx INCY yte IOVA Iovance Biotherapeutics SGEN Seagen STRO Sutro Biopharma VYGR Voyager Therapeutics ALLO Allogene Therapeutics CGEN Compugen KURA Kura Oncology ACET Adicet Bio CTIC CTi Biopharma Corp RGNX Regenxbio ADAP Adaptimmune Therapeutics Plc ADVM Adverum Biotechnologies BCAB Bioatla CUE Cue Biopharma SPPI Spectrum Pharmaceuticals URGN UroGen Pharma Ltd AMAM Ambrx Biopharma American Depositary Shares LVTX LAVA Therapeutics NV SANA Sana Biotechnology VSTM Verastem HOWL Werewolf Therapeutics PRLD Prelude Therapeutics AKBA Akebia Ther IDRA Idera Pharmaceuticals SMMT Summit Therapeutics PLC TIL Instil Bio ADMA ADMA Biologics BMRN Biomarin Pharmaceutical BTX Brooklyn Immunotherapeutics NXTC NextCure SG Sweetgreen TRIL Trillium Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jeffrey Hung (MORGAN STANLEY)